Results 71 to 80 of about 937 (121)

2024 Update of Chinese Guidelines for Management of Hyperuricemia and Gout Part II: Recommendations for Patients With Common Comorbidities. [PDF]

Int J Rheum Dis
Li C, Sun M, Liu Z, Li D, Wang C, Tian Z, Dai Y, Feng Z, Xu C, Zhao D, Wei F, Ban B, Xie C, An Z, Liu J, Li Z, He Y, Li X, Yan F, Han L, Ma L, Cheng X, Liu T, Luo X, Luo X, Cui L, Gong Y, Wang C, Chen Y, Lyu Z, Yip RML, Zhao J.   +31 more
europepmc   +1 more source

DRESS Syndrome - Rare but Potentially Fatal Drug Reaction. [PDF]

Hawaii J Health Soc Welf
Fukuyama TH, Yamat BR, Tokeshi J.
europepmc   +1 more source

Comparative Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drug Versus Colchicine Use When Initiating Urate-Lowering Therapy Among Patients With Gout: Target Trial Emulations. [PDF]

Arthritis Rheumatol
Yokose C, McCormick N, Lu N, Jiang B, Tan K, Chigurupati S, Rai SK, Challener G, Aviña-Zubieta JA, Cipolletta E, Abhishek A, Gaffo A, Januzzi JL, Zhang Y, Choi HK.   +14 more
europepmc   +1 more source

Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study. [PDF]

J Intern Med
Jeon M, Cho Y, Bea S, You W, Cho SK, Ryu S, Chang Y, Shin JY.   +7 more
europepmc   +1 more source

Gouty tophi of the pinna. [PDF]

BMJ Case Rep
Gurney M, Morris S, Saw K.
europepmc   +1 more source

Group-based trajectory modeling to assess adherence to chronic urate-lowering therapies among commercially insured US adults with gout. [PDF]

J Manag Care Spec Pharm
Rizk JG, Qato DM, Bingham CO, dosReis S.
europepmc   +1 more source

Roles of traditional Chinese medicine extracts in hyperuricemia and gout treatment: Mechanisms and clinical applications. [PDF]

World J Gastroenterol
Wang YB, Jin CZ.
europepmc   +1 more source

Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score-Matched Cohort Study. [PDF]

Arthritis Care Res (Hoboken)
Sun W, Cui L, Terkeltaub R, Chen Y, Li X, Cheng X, Liu T, Dalbeth N, Li C.   +8 more
europepmc   +1 more source

Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for gout. [PDF]

Rheumatology (Oxford)
Zhao SS, Cuthbertson DJ, Alam U.
europepmc   +1 more source